Core Scientific vs Nebius Group
Nebius Group is the larger business, with $530m of revenue in fiscal 2025 against $319m for Core Scientific (1.7 times as much). Nebius Group grew faster (479.0% against -37.5%). Nebius Group kept more of each dollar of sales as profit: a net margin of 15.6% against -90.5%.
| Latest fiscal year | Core ScientificCORZ, 2025 | Nebius GroupNBIS, 2025 |
|---|---|---|
| Revenue | $319m | $530m |
| Revenue growth | -37.5% | 479.0% |
| Net income | −$289m | $82.5m |
| Operating margin | -77.0% | -115.5% |
| Net margin | -90.5% | 15.6% |
| Return on equity | — | 2.1% |
| Free cash flow | −$451m | −$3.68bn |
| Cash | $311m | $3.68bn |
| Total debt | $1.08bn | $4.84bn |
| Debt to equity | — | 105.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 325 | — |
| Market value | $4.50bn | $38.31bn |
| Price vs our value range | — | — |
| Moat score | 16 (Weak) | — |
| Insider trades, 12 months | 5 buys, 49 sales | 11 buys, 126 sales |